vs
Akebia Therapeutics, Inc.（AKBA）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
RCI HOSPITALITY HOLDINGS, INC.的季度营收约是Akebia Therapeutics, Inc.的1.2倍（$70.9M vs $57.6M），Akebia Therapeutics, Inc.同比增速更快（23.9% vs -3.1%），Akebia Therapeutics, Inc.自由现金流更多（$31.1M vs $11.5M），过去两年Akebia Therapeutics, Inc.的营收复合增速更高（32.9% vs -2.0%）
Akebia Therapeutics是一家专注于肾病领域的生物制药企业，核心业务覆盖药物研发、临床试验及商业化推广全流程，主要开发针对慢性肾病相关贫血等适应症的创新疗法，面向全球市场，致力于满足肾病治疗领域未被满足的临床需求。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
AKBA vs RICK — 直观对比
营收规模更大
RICK
是对方的1.2倍
$57.6M
营收增速更快
AKBA
高出27.1%
-3.1%
自由现金流更多
AKBA
多$19.6M
$11.5M
两年增速更快
AKBA
近两年复合增速
-2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.6M | $70.9M |
| 净利润 | — | $-5.5M |
| 毛利率 | 78.2% | — |
| 营业利润率 | -14.8% | -0.7% |
| 净利率 | — | -7.8% |
| 营收同比 | 23.9% | -3.1% |
| 净利润同比 | — | -2354.9% |
| 每股收益（稀释后） | $-0.05 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AKBARICK
| Q4 25 | $57.6M | — | ||
| Q3 25 | $58.8M | $70.9M | ||
| Q2 25 | $62.5M | $71.1M | ||
| Q1 25 | $57.3M | $65.9M | ||
| Q4 24 | $46.5M | $71.5M | ||
| Q3 24 | $37.4M | $73.2M | ||
| Q2 24 | $43.6M | $76.2M | ||
| Q1 24 | $32.6M | $72.3M |
净利润AKBARICK
| Q4 25 | — | — | ||
| Q3 25 | $540.0K | $-5.5M | ||
| Q2 25 | $247.0K | $4.1M | ||
| Q1 25 | $6.1M | $3.2M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | $-20.0M | $244.0K | ||
| Q2 24 | $-8.6M | $-5.2M | ||
| Q1 24 | $-18.0M | $774.0K |
毛利率AKBARICK
| Q4 25 | 78.2% | — | ||
| Q3 25 | 84.0% | — | ||
| Q2 25 | 84.1% | — | ||
| Q1 25 | 86.7% | — | ||
| Q4 24 | 56.2% | — | ||
| Q3 24 | 62.2% | — | ||
| Q2 24 | 60.9% | — | ||
| Q1 24 | 64.4% | — |
营业利润率AKBARICK
| Q4 25 | -14.8% | — | ||
| Q3 25 | 7.6% | -0.7% | ||
| Q2 25 | 22.6% | 12.2% | ||
| Q1 25 | 23.6% | 12.4% | ||
| Q4 24 | -30.8% | 19.5% | ||
| Q3 24 | -33.4% | 4.8% | ||
| Q2 24 | -20.0% | -3.3% | ||
| Q1 24 | -45.8% | 6.4% |
净利率AKBARICK
| Q4 25 | — | — | ||
| Q3 25 | 0.9% | -7.8% | ||
| Q2 25 | 0.4% | 5.7% | ||
| Q1 25 | 10.7% | 4.9% | ||
| Q4 24 | — | 12.6% | ||
| Q3 24 | -53.5% | 0.3% | ||
| Q2 24 | -19.7% | -6.9% | ||
| Q1 24 | -55.2% | 1.1% |
每股收益（稀释后）AKBARICK
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $0.00 | $-0.60 | ||
| Q2 25 | $0.00 | $0.46 | ||
| Q1 25 | $0.03 | $0.36 | ||
| Q4 24 | $-0.10 | $1.01 | ||
| Q3 24 | $-0.10 | $0.04 | ||
| Q2 24 | $-0.04 | $-0.56 | ||
| Q1 24 | $-0.09 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $184.8M | $33.7M |
| 总债务越低越好 | $48.3M | $238.2M |
| 股东权益账面价值 | $32.6M | $261.1M |
| 总资产 | $376.6M | $596.9M |
| 负债/权益比越低杠杆越低 | 1.48× | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资AKBARICK
| Q4 25 | $184.8M | — | ||
| Q3 25 | $166.4M | $33.7M | ||
| Q2 25 | $137.3M | $29.3M | ||
| Q1 25 | $113.4M | $32.7M | ||
| Q4 24 | $51.9M | $34.7M | ||
| Q3 24 | $34.0M | $32.4M | ||
| Q2 24 | $39.5M | $34.9M | ||
| Q1 24 | $42.0M | $20.0M |
总债务AKBARICK
| Q4 25 | $48.3M | — | ||
| Q3 25 | $47.6M | $238.2M | ||
| Q2 25 | $47.1M | $243.8M | ||
| Q1 25 | $46.5M | $244.1M | ||
| Q4 24 | $38.7M | — | ||
| Q3 24 | $38.4M | $241.1M | ||
| Q2 24 | $38.0M | — | ||
| Q1 24 | $30.1M | — |
股东权益AKBARICK
| Q4 25 | $32.6M | — | ||
| Q3 25 | $41.6M | $261.1M | ||
| Q2 25 | $29.2M | $269.5M | ||
| Q1 25 | $24.6M | $268.8M | ||
| Q4 24 | $-49.2M | $269.0M | ||
| Q3 24 | $-50.4M | $263.4M | ||
| Q2 24 | $-33.8M | $271.2M | ||
| Q1 24 | $-27.3M | $285.8M |
总资产AKBARICK
| Q4 25 | $376.6M | — | ||
| Q3 25 | $364.2M | $596.9M | ||
| Q2 25 | $345.6M | $597.4M | ||
| Q1 25 | $310.2M | $589.8M | ||
| Q4 24 | $220.7M | $586.2M | ||
| Q3 24 | $207.1M | $584.4M | ||
| Q2 24 | $220.2M | $601.0M | ||
| Q1 24 | $225.5M | $609.9M |
负债/权益比AKBARICK
| Q4 25 | 1.48× | — | ||
| Q3 25 | 1.15× | 0.91× | ||
| Q2 25 | 1.61× | 0.90× | ||
| Q1 25 | 1.89× | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $31.1M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $31.1M | $11.5M |
| 自由现金流率自由现金流/营收 | 53.9% | 16.2% |
| 资本支出强度资本支出/营收 | 0.1% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $67.7M | $34.9M |
8季度趋势，按日历期对齐
经营现金流AKBARICK
| Q4 25 | $31.1M | — | ||
| Q3 25 | $28.1M | $13.7M | ||
| Q2 25 | $22.3M | $13.8M | ||
| Q1 25 | $-13.6M | $8.5M | ||
| Q4 24 | $-4.5M | $13.3M | ||
| Q3 24 | $-6.7M | $15.7M | ||
| Q2 24 | $-10.1M | $15.8M | ||
| Q1 24 | $-19.4M | $10.8M |
自由现金流AKBARICK
| Q4 25 | $31.1M | — | ||
| Q3 25 | $28.0M | $11.5M | ||
| Q2 25 | $22.2M | $10.1M | ||
| Q1 25 | $-13.6M | $5.7M | ||
| Q4 24 | $-4.5M | $7.6M | ||
| Q3 24 | $-6.7M | $10.3M | ||
| Q2 24 | $-10.1M | $9.3M | ||
| Q1 24 | — | $3.2M |
自由现金流率AKBARICK
| Q4 25 | 53.9% | — | ||
| Q3 25 | 47.7% | 16.2% | ||
| Q2 25 | 35.6% | 14.2% | ||
| Q1 25 | -23.7% | 8.6% | ||
| Q4 24 | -9.6% | 10.6% | ||
| Q3 24 | -17.9% | 14.0% | ||
| Q2 24 | -23.1% | 12.3% | ||
| Q1 24 | — | 4.4% |
资本支出强度AKBARICK
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.1% | 3.2% | ||
| Q2 25 | 0.2% | 5.2% | ||
| Q1 25 | 0.0% | 4.3% | ||
| Q4 24 | 0.0% | 8.0% | ||
| Q3 24 | 0.0% | 7.3% | ||
| Q2 24 | 0.1% | 8.4% | ||
| Q1 24 | 0.0% | 10.6% |
现金转化率AKBARICK
| Q4 25 | — | — | ||
| Q3 25 | 52.05× | — | ||
| Q2 25 | 90.47× | 3.40× | ||
| Q1 25 | -2.22× | 2.65× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AKBA
| Auryxia | $48.1M | 84% |
| Vafseo | $6.2M | 11% |
| License Collaboration And Other Revenue | $3.3M | 6% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
